NRG GI002

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Gastrointestinal, Rectal

Status:

Closed

A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer

NCT#02921256

GI002 is permanently closed to accrual effective February 22, 2021. Sites need to continue to collect long-term follow-up data on enrolled patients.

As of February 12, 2018 Arm 2 is permanently closed having met its enrollment goal.

As of Tuesday, May 14th, 2019 at 9:00 am EST, NRG-GI002 (Arm 1 and 3) has met its accrual goal and is temporarily suspended.